中文摘要 |
Norathyriol與各種acidic anhydride和acyl chloride酯化形成六種norathyriol酯類,以適當原料經由Friedel-Crafts acylation所產生之benzophenone precursor,再經鹽基催化,脫除甲醇,進行環化可合成得norathyriol tetramethyl ether. Norathyriol tetramethyl ether與BCl3進行選擇性demethylation反應而可合成得2,4-di-C-prenyl-1-hydroxy-3, 6, 7-trimethoxyxanthone,本實驗結果顯示norathyriol衍生物之抗血小板活性以norathyriol tetrapropionate與norathyriol tetracrotonate最強,其次是norathyriol tetracinnamate 及norathyriol tetramethyl ether。 |
英文摘要 |
Six norathyriol esters have been synthesized from various acidic anhydride and acyl chloride. Norathyriol tetramethyl ether was synthesized from benzophenone precursor by Friedel-Crafts acylation, and subsequently base-catalyzed cyclization to eliminate methanol. Selective demethylation of norathyriol tetramethyl ether with boron trichloride gave l-hydroxy-3, 6, 7-trimethoxyxanthone and then reacted with prenyl bromide to give 2, 4-di-C-prenyl-1-hydroxy-3, 6, 7-trimethoxyxanthone. According to the results of this study, norathyriol tetrapropionate and norathyriol tetracrotonate are the most potent antiplatelet compound, and the norathyriol tetracinnamate and norathyriol tetramethyl ether showed significant antiplatelet effects. |